Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada

Kymberly D S Watt, Kelly W. Burak, Marc Deschênes, Les Lilly, Denis Marleau, Paul Marotta, Andrew Mason, Kevork M. Peltekian, Eberhard Renner, Eric M. Yoshida

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Allograft failure secondary to recurrence of hepatitis C virus (HCV) infection is the most common cause of death and retransplantation among recipients with HCV infection. It has been suggested that patients transplanted for HCV have had worse outcomes in more recent years than in previous years (the 'era effect'). A Canadian transplantation registry database was analyzed to determine the outcomes of patients transplanted over the years for HCV. The results of the present analysis of 1002 patients show that the 'era effect' was not seen in liver transplantation recipients with HCV in Canada, because no survival difference was noted based on the year of transplantation. All groups had overall two-year and five-year survival rates of 76% to 83% and 69% to 72%, respectively. The present study's national results prove continued benefit to transplantation of HCV Patients.

Original languageEnglish (US)
Pages (from-to)153-154
Number of pages2
JournalCanadian Journal of Gastroenterology
Volume22
Issue number2
StatePublished - Feb 2008

Fingerprint

Hepatitis C
Hepacivirus
Liver Transplantation
Canada
Survival
Transplantation
Virus Diseases
Allografts
Registries
Cause of Death
Survival Rate
Databases
Recurrence

Keywords

  • Era effect
  • Hepatitis C
  • Survival
  • Transplantation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Watt, K. D. S., Burak, K. W., Deschênes, M., Lilly, L., Marleau, D., Marotta, P., ... Yoshida, E. M. (2008). Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. Canadian Journal of Gastroenterology, 22(2), 153-154.

Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. / Watt, Kymberly D S; Burak, Kelly W.; Deschênes, Marc; Lilly, Les; Marleau, Denis; Marotta, Paul; Mason, Andrew; Peltekian, Kevork M.; Renner, Eberhard; Yoshida, Eric M.

In: Canadian Journal of Gastroenterology, Vol. 22, No. 2, 02.2008, p. 153-154.

Research output: Contribution to journalArticle

Watt, KDS, Burak, KW, Deschênes, M, Lilly, L, Marleau, D, Marotta, P, Mason, A, Peltekian, KM, Renner, E & Yoshida, EM 2008, 'Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada', Canadian Journal of Gastroenterology, vol. 22, no. 2, pp. 153-154.
Watt KDS, Burak KW, Deschênes M, Lilly L, Marleau D, Marotta P et al. Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. Canadian Journal of Gastroenterology. 2008 Feb;22(2):153-154.
Watt, Kymberly D S ; Burak, Kelly W. ; Deschênes, Marc ; Lilly, Les ; Marleau, Denis ; Marotta, Paul ; Mason, Andrew ; Peltekian, Kevork M. ; Renner, Eberhard ; Yoshida, Eric M. / Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada. In: Canadian Journal of Gastroenterology. 2008 ; Vol. 22, No. 2. pp. 153-154.
@article{49e478ad256a4ec293877fb4ec7ae892,
title = "Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada",
abstract = "Allograft failure secondary to recurrence of hepatitis C virus (HCV) infection is the most common cause of death and retransplantation among recipients with HCV infection. It has been suggested that patients transplanted for HCV have had worse outcomes in more recent years than in previous years (the 'era effect'). A Canadian transplantation registry database was analyzed to determine the outcomes of patients transplanted over the years for HCV. The results of the present analysis of 1002 patients show that the 'era effect' was not seen in liver transplantation recipients with HCV in Canada, because no survival difference was noted based on the year of transplantation. All groups had overall two-year and five-year survival rates of 76{\%} to 83{\%} and 69{\%} to 72{\%}, respectively. The present study's national results prove continued benefit to transplantation of HCV Patients.",
keywords = "Era effect, Hepatitis C, Survival, Transplantation",
author = "Watt, {Kymberly D S} and Burak, {Kelly W.} and Marc Desch{\^e}nes and Les Lilly and Denis Marleau and Paul Marotta and Andrew Mason and Peltekian, {Kevork M.} and Eberhard Renner and Yoshida, {Eric M.}",
year = "2008",
month = "2",
language = "English (US)",
volume = "22",
pages = "153--154",
journal = "Canadian Journal of Gastroenterology and Hepatology",
issn = "2291-2789",
publisher = "Pulsus Group Inc.",
number = "2",

}

TY - JOUR

T1 - Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada

AU - Watt, Kymberly D S

AU - Burak, Kelly W.

AU - Deschênes, Marc

AU - Lilly, Les

AU - Marleau, Denis

AU - Marotta, Paul

AU - Mason, Andrew

AU - Peltekian, Kevork M.

AU - Renner, Eberhard

AU - Yoshida, Eric M.

PY - 2008/2

Y1 - 2008/2

N2 - Allograft failure secondary to recurrence of hepatitis C virus (HCV) infection is the most common cause of death and retransplantation among recipients with HCV infection. It has been suggested that patients transplanted for HCV have had worse outcomes in more recent years than in previous years (the 'era effect'). A Canadian transplantation registry database was analyzed to determine the outcomes of patients transplanted over the years for HCV. The results of the present analysis of 1002 patients show that the 'era effect' was not seen in liver transplantation recipients with HCV in Canada, because no survival difference was noted based on the year of transplantation. All groups had overall two-year and five-year survival rates of 76% to 83% and 69% to 72%, respectively. The present study's national results prove continued benefit to transplantation of HCV Patients.

AB - Allograft failure secondary to recurrence of hepatitis C virus (HCV) infection is the most common cause of death and retransplantation among recipients with HCV infection. It has been suggested that patients transplanted for HCV have had worse outcomes in more recent years than in previous years (the 'era effect'). A Canadian transplantation registry database was analyzed to determine the outcomes of patients transplanted over the years for HCV. The results of the present analysis of 1002 patients show that the 'era effect' was not seen in liver transplantation recipients with HCV in Canada, because no survival difference was noted based on the year of transplantation. All groups had overall two-year and five-year survival rates of 76% to 83% and 69% to 72%, respectively. The present study's national results prove continued benefit to transplantation of HCV Patients.

KW - Era effect

KW - Hepatitis C

KW - Survival

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=42449116709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449116709&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 153

EP - 154

JO - Canadian Journal of Gastroenterology and Hepatology

JF - Canadian Journal of Gastroenterology and Hepatology

SN - 2291-2789

IS - 2

ER -